Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 20187 [05-7655]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 73 / Monday, April 18, 2005 / Notices
December 17, 2004, (3) ML050680216
for the licensee’s supplement of March
1, 2005 and (4) ML050960492 for the
licensee’s supplement of March 29,
2005. If you do not have access to
ADAMS or if there are problems in
accessing the documents located in
ADAMS, contact the NRC’s Public
Document Room (PDR) Reference staff
at 1–800–397–4209, 301–415–4737, or
by e-mail to pdr@nrc.gov.
These documents may also be viewed
electronically on the public computers
located at the NRC’s PDR, O 1 F21, One
White Flint North, 11555 Rockville
Pike, Rockville, MD 20852. The PDR
reproduction contractor will copy
documents for a fee.
Dated at Rockville, Maryland, this 8th day
of April, 2005.
For the Nuclear Regulatory Commission.
Daniel M. Gillen,
Deputy Director, Division of Waste
Management and Environmental Protection,
Office of Nuclear Material Safety and
Safeguards.
[FR Doc. 05–7657 Filed 4–15–05; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Updated notice of meeting.
AGENCY:
SUMMARY: The U.S. Nuclear Regulatory
Commission will convene a meeting of
the Advisory Committee on the Medical
Uses of Isotopes (ACMUI) on April 20
and 21, 2005. Although the dates of the
ACMUI public meeting remain April 20
and 21, as originally published in the
February 28, 2005 notice (see 70 FR
9611), this notice is meant to alert
interested parties that the time for the
ACMUI’s briefing to the Commission
has changed. See heading below entitled
‘‘Date and Time for Commission
Briefing’’ for details. A sample of agenda
items to be discussed during the public
sessions includes: (1) Status of
Rulemaking: Pt. 35 Training and
Experience; (2) Status and Update:
Redefining Medical Events; (3) Case
Experience in Using I–125 Seeds as
Markers; (4) FDA Radiation Dose Limits
for Human Research Subjects Using
Certain Radiolabeled Drugs, and (5)
Establishing Guidance on Exceeding
Dose Limits for Members of the Public
who would serve as Caregivers to
Persons undergoing
Radiopharmaceutical Therapy. To
review the agenda, see https://
VerDate jul<14>2003
16:08 Apr 15, 2005
Jkt 205001
www.nrc.gov/reading-rm/doccollections/acmui/agenda/ or contact
arm@nrc.gov.
Purpose: Discuss issues related to 10
CFR 35, Medical Use of Byproduct
Material.
Date and Time for Closed Session
Meeting: April 21, 2005, from 8 a.m. to
10 a.m. This session will be closed so
that NRC staff can brief the ACMUI on
sensitive information regarding
protective security measures, and so
that the ACMUI can discuss internal
personnel matters.
Dates and Times for Public Meetings:
April 20, 2005, from 8 a.m. to 5 p.m.;
and April 21, 2005, from 10 a.m. to 5
p.m.
Address for Public Meetings: Bethesda
North Marriott Hotel, 5701 Marinelli
Road, North Bethesda, MD 20552–2785.
Date and Time for Commission
Briefing: April 20, 2005, from 3:15 to
4:45 p.m.
FOR FURTHER INFORMATION CONTACT:
Angela R. McIntosh, telephone (301)
415–5030; e-mail arw@nrc.gov of the
Office of Nuclear Material Safety and
Safeguards, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001.
Conduct of the Meeting
Leon S. Malmud, M.D., will chair the
meeting. Dr. Malmud will conduct the
meeting in a manner that will facilitate
the orderly conduct of business. The
following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a
written statement should submit a
reproducible copy to Angela R.
McIntosh, U.S. Nuclear Regulatory
Commission, Two White Flint North,
Mail Stop T8F5, 11545 Rockville Pike,
Rockville, MD 20852–2738. Submittals
must be postmarked by April 1, 2005,
and must pertain to the topics on the
agenda for the meeting.
2. Questions from members of the
public will be permitted during the
meeting, at the discretion of the
Chairman.
3. The transcript and written
comments will be available for
inspection on NRC’s Web site
(www.nrc.gov) and at the NRC Public
Document Room, 11555 Rockville Pike,
Rockville, MD 20852–2738, telephone
(800) 397–4209, on or about July 20,
2005. This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in Title 10,
U.S. Code of Federal Regulations, Part 7.
4. Attendees are requested to notify
Angela R. McIntosh at (301) 415–5030 of
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
20187
their planned attendance if special
services, such as for the hearing
impaired, are necessary.
Dated at Rockville, Maryland, this 12th day
of April, 2005.
For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 05–7655 Filed 4–17–05; 8:45 am]
BILLING CODE 7590–01–P
OVERSEAS PRIVATE INVESTMENT
CORPORATION
Sunshine Act; Board of Directors
Meeting
Thursday, April 28,
2005, 10 a.m. (open portion); 10:15 a.m.
(closed portion).
PLACE: Offices of the Corporation,
Twelfth Floor Board Room, 1100 New
York Avenue, NW., Washington, DC.
STATUS: Meeting open to the Public from
10 a.m. to 10:15 a.m.; Closed portion
will commence at 10:15 a.m. (approx.)
MATTERS TO BE CONSIDERED:
1. President’s Report.
2. Testimonials: Alan P. Larson, Peter
S. Watson and Grant L. Aldonas.
3. Approval of January 27, 2005
minutes (open portion).
FURTHER MATTERS TO BE CONSIDERED:
(Closed to the public 10:15 a.m.)
1. Finance Project—India, Indonesia,
Sri Lanka, Thailand, Bangladesh, Kenya,
Malaysia.
2. Finance Project—Zambia.
3. Finance Project—Asia.
4. Finance Project—Afghanistan.
5. Approval of January 27, 2005
Minutes (closed portion).
6. Pending Major Projects.
7. Reports. Update on project in India
CONTACT PERSON FOR INFORMATION:
Information on the meeting may be
obtained from Connie M. Downs at (202)
336–8438.
TIME AND DATE:
Dated: April 14, 2005.
Connie M. Downs,
Corporate Secretary, Overseas Private
Investment Corporation.
[FR Doc. 05–7782 Filed 4–14–05; 12:40 pm]
BILLING CODE 3210–01–M
POSTAL RATE COMMISSION
[Order No. 1436; Docket No. R2005–1]
Postal Rate and Fee Changes
Postal Rate Commission.
Notice and order in omnibus
rate filing.
AGENCY:
ACTION:
May 2, 2005: Deadline for
notices of intervention, answers to
DATES:
E:\FR\FM\18APN1.SGM
18APN1
]]>Agencies
[Federal Register Volume 70, Number 73 (Monday, April 18, 2005)]
[Notices]
[Page 20187]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7655]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Updated notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on
April 20 and 21, 2005. Although the dates of the ACMUI public meeting
remain April 20 and 21, as originally published in the February 28,
2005 notice (see 70 FR 9611), this notice is meant to alert interested
parties that the time for the ACMUI's briefing to the Commission has
changed. See heading below entitled ``Date and Time for Commission
Briefing'' for details. A sample of agenda items to be discussed during
the public sessions includes: (1) Status of Rulemaking: Pt. 35 Training
and Experience; (2) Status and Update: Redefining Medical Events; (3)
Case Experience in Using I-125 Seeds as Markers; (4) FDA Radiation Dose
Limits for Human Research Subjects Using Certain Radiolabeled Drugs,
and (5) Establishing Guidance on Exceeding Dose Limits for Members of
the Public who would serve as Caregivers to Persons undergoing
Radiopharmaceutical Therapy. To review the agenda, see https://
www.nrc.gov/reading-rm/doc-collections/acmui/agenda/ or contact
arm@nrc.gov.
Purpose: Discuss issues related to 10 CFR 35, Medical Use of
Byproduct Material.
Date and Time for Closed Session Meeting: April 21, 2005, from 8
a.m. to 10 a.m. This session will be closed so that NRC staff can brief
the ACMUI on sensitive information regarding protective security
measures, and so that the ACMUI can discuss internal personnel matters.
Dates and Times for Public Meetings: April 20, 2005, from 8 a.m. to
5 p.m.; and April 21, 2005, from 10 a.m. to 5 p.m.
Address for Public Meetings: Bethesda North Marriott Hotel, 5701
Marinelli Road, North Bethesda, MD 20552-2785.
Date and Time for Commission Briefing: April 20, 2005, from 3:15 to
4:45 p.m.
FOR FURTHER INFORMATION CONTACT: Angela R. McIntosh, telephone (301)
415-5030; e-mail arw@nrc.gov of the Office of Nuclear Material Safety
and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001.
Conduct of the Meeting
Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will
conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit a
reproducible copy to Angela R. McIntosh, U.S. Nuclear Regulatory
Commission, Two White Flint North, Mail Stop T8F5, 11545 Rockville
Pike, Rockville, MD 20852-2738. Submittals must be postmarked by April
1, 2005, and must pertain to the topics on the agenda for the meeting.
2. Questions from members of the public will be permitted during
the meeting, at the discretion of the Chairman.
3. The transcript and written comments will be available for
inspection on NRC's Web site (www.nrc.gov) and at the NRC Public
Document Room, 11555 Rockville Pike, Rockville, MD 20852-2738,
telephone (800) 397-4209, on or about July 20, 2005. This meeting will
be held in accordance with the Atomic Energy Act of 1954, as amended
(primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C.
App); and the Commission's regulations in Title 10, U.S. Code of
Federal Regulations, Part 7.
4. Attendees are requested to notify Angela R. McIntosh at (301)
415-5030 of their planned attendance if special services, such as for
the hearing impaired, are necessary.
Dated at Rockville, Maryland, this 12th day of April, 2005.
For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 05-7655 Filed 4-17-05; 8:45 am]
BILLING CODE 7590-01-P
